NCT02951741View on ClinicalTrials.gov

Revision Total Hip Replacement Arthroplasty and Hematologic Variables

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Avascular Necrosis of HipDegenerative Hip Joint Disease
Interventions
OTHER

RTHRA group

hematologic variables measurement in patients undergoing revision total hip replacement

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT02951741 - Revision Total Hip Replacement Arthroplasty and Hematologic Variables | Biotech Hunter | Biotech Hunter